Page last updated: 2024-08-24

diminazene aceturate and Alloxan Diabetes

diminazene aceturate has been researched along with Alloxan Diabetes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Gaikwad, AB; Kale, A; Sankrityayan, H1
Gaikwad, AB; Malek, V; Sharma, N1
Gaikwad, AB; Sharma, N2
Gaikwad, AB; Malek, V; Sankrityayan, H; Sharma, N1

Other Studies

5 other study(ies) available for diminazene aceturate and Alloxan Diabetes

ArticleYear
Inhibition of endoplasmic reticulum stress combined with activation of angiotensin-converting enzyme 2: novel approach for the prevention of endothelial dysfunction in type 1 diabetic rats.
    Canadian journal of physiology and pharmacology, 2022, Volume: 100, Issue:3

    Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diminazene; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Endothelium, Vascular; Male; Oxidative Stress; Rats, Wistar; Streptozocin; Taurochenodeoxycholic Acid

2022
Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy.
    Pharmacological reports : PR, 2019, Volume: 71, Issue:5

    Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diminazene; Drug Therapy, Combination; Enzyme Activation; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats, Wistar; Streptozocin; Thiorphan

2019
Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Angiotensin-Converting Enzyme 2; Animals; Brain; Diabetes Mellitus, Experimental; Diminazene; Hyperglycemia; Imidazoles; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Nitrites; Rats, Wistar; Receptor, Angiotensin, Type 2; Reperfusion Injury; Sulfonamides; Thiophenes

2020
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
    Environmental toxicology and pharmacology, 2020, Volume: 80

    Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes

2020
Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
    Life sciences, 2019, Mar-15, Volume: 221

    Topics: Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diminazene; Fibrosis; Inflammation; Kidney; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Streptozocin; Telmisartan; Thiorphan

2019